Therapeutic Drug Monitoring Consumables Market Share & Trends Analysis Report, By Product (Blood Collection Tubes, Syringes and Needles, Transfer Pipettes, Calibration Standards and Controls, Centrifuge Tubes, Extraction Supplies), By Technology, By Class of Drugs, By End User, By Region, and Segment Forecasts, 2024-2031

Report Id: 2917 Pages: 170 Last Updated: 05 February 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Therapeutic Drug Monitoring Consumables Market

Global Therapeutic Drug Monitoring Consumables Market- By Product

  • Blood Collection Tubes
  • Syringes and Needles
  • Transfer Pipettes
  • Calibration Standards and Controls
  • Centrifuge Tubes
  • Extraction Supplies

therapeutic

Global Therapeutic Drug Monitoring Consumables Market – By Technology

  • Immunoassay Consumables
  • Chromatography & Mass Spectrometry Consumables

Global Therapeutic Drug Monitoring Consumables Market – By Class of Drugs

  • Antiepileptic Drugs (AEDs)
  • Antiarrhythmic Drugs
  • Immunosuppressant Drugs
  • Other Drug Classes

Global Therapeutic Drug Monitoring Consumables Market – By End-User

  • Hospital Laboratories
  • Commercial & Private Laboratories
  • Research and Academic Institutes

Global Therapeutic Drug Monitoring Consumables Market – By Region

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Chapter 1.       Methodology and Scope

1.1.      Research Methodology

1.2.      Research Scope & Assumptions

Chapter 2.       Executive Summary

Chapter 3.       Global Therapeutic Drug Monitoring Consumables Market Snapshot

Chapter 4.       Global Therapeutic Drug Monitoring Consumables Market Variables, Trends & Scope

4.1.      Market Segmentation & Scope

4.2.      Drivers

4.3.      Challenges

4.4.      Trends

4.5.      Investment and Funding Analysis

4.6.      Porter's Five Forces Analysis

4.7.      Incremental Opportunity Analysis (US$ MN), 2024-2031

4.8.      Global Therapeutic Drug Monitoring Consumables Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031

4.9.      Competitive Landscape & Market Share Analysis, By Key Player (2023)

4.10.    Use/impact of AI on Therapeutic Drug Monitoring Consumables Industry Trends

Chapter 5.       Therapeutic Drug Monitoring Consumables Market Segmentation 1: By Product, Estimates & Trend Analysis

5.1.      Market Share by Product, 2023 & 2031

5.2.      Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Product:

5.2.1.   Blood Collection Tubes

5.2.2.   Syringes and Needles

5.2.3.   Transfer Pipettes

5.2.4.   Calibration Standards and Controls

5.2.5.   Centrifuge Tubes

5.2.6.   Extraction Supplies

Chapter 6.       Therapeutic Drug Monitoring Consumables Market Segmentation 2: By Technology, Estimates & Trend Analysis

6.1.      Market Share by Technology, 2023 & 2031

6.2.      Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Technologys:

6.2.1.   Immunoassay Consumables

6.2.2.   Chromatography & Mass Spectrometry Consumables

Chapter 7.       Therapeutic Drug Monitoring Consumables Market Segmentation 3: By Class of Drugs, Estimates & Trend Analysis

7.1.      Market Share by Class of Drugs, 2023 & 2031

7.2.      Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Class of Drugss:

7.2.1.   Antiepileptic Drugs (AEDs)

7.2.2.   Antiarrhythmic Drugs

7.2.3.   Immunosuppressant Drugs

7.2.4.   Other Drug Classes

Chapter 8.       Therapeutic Drug Monitoring Consumables Market Segmentation 4: By End-User, Estimates & Trend Analysis

8.1.      Market Share by End-User, 2023 & 2031

8.2.      Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End-Users:

8.2.1.   Hospital Laboratories

8.2.2.   Commercial & Private Laboratories

8.2.3.   Research and Academic Institutes

Chapter 9.       Therapeutic Drug Monitoring Consumables Market Segmentation 5: Regional Estimates & Trend Analysis

9.1.      Global Therapeutic Drug Monitoring Consumables Market, Regional Snapshot 2023 & 2031

9.2.      North America

9.2.1.   North America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

9.2.1.1.            US

9.2.1.2.            Canada

9.2.2.   North America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031

9.2.3.   North America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031

9.2.4.   North America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Class of Drugs, 2024-2031

9.2.5.   North America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031

9.3.      Europe

9.3.1.   Europe Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

9.3.1.1.            Germany

9.3.1.2.            U.K.

9.3.1.3.            France

9.3.1.4.            Italy

9.3.1.5.            Spain

9.3.1.6.            Rest of Europe

9.3.2.   Europe Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031

9.3.3.   Europe Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031

9.3.4.   Europe Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Class of Drugs, 2024-2031

9.3.5.   Europe Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031

9.4.      Asia Pacific

9.4.1.   Asia Pacific Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

9.4.1.1.            India

9.4.1.2.            China

9.4.1.3.            Japan

9.4.1.4.            Australia

9.4.1.5.            South Korea

9.4.1.6.            Hong Kong

9.4.1.7.            Southeast Asia

9.4.1.8.            Rest of Asia Pacific

9.4.2.   Asia Pacific Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031

9.4.3.   Asia Pacific Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031

9.4.4.   Asia Pacific Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts By Class of Drugs, 2024-2031

9.4.5.   Asia Pacific Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031

9.5.      Latin America

9.5.1.   Latin America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031

9.5.1.1.            Brazil

9.5.1.2.            Mexico

9.5.1.3.            Rest of Latin America

9.5.2.   Latin America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031

9.5.3.   Latin America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031

9.5.4.   Latin America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Class of Drugs, 2024-2031

9.5.5.   Latin America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031

9.6.      Middle East & Africa

9.6.1.   Middle East & Africa Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031

9.6.1.1.            GCC Countries

9.6.1.2.            Israel

9.6.1.3.            South Africa

9.6.1.4.            Rest of Middle East and Africa

9.6.2.   Middle East & Africa Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031

9.6.3.   Middle East & Africa Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031

9.6.4.   Middle East & Africa Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Class of Drugs, 2024-2031

9.6.5.   Middle East & Africa Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031

Chapter 10.     Competitive Landscape

10.1.    Major Mergers and Acquisitions/Strategic Alliances

10.2.    Company Profiles

10.2.1. Abbott Laboratories

10.2.1.1.          Business Overview

10.2.1.2.          Key Product/Service Offerings

10.2.1.3.          Financial PerProductance

10.2.1.4.          Geographical Presence

10.2.1.5.          Recent Developments with Business Strategy

10.2.2. Alere, Inc. 

10.2.3. bioMérieux SA

10.2.4. Bio-Rad Laboratories

10.2.5. Danaher Corporation 

10.2.6. Exagen Inc

10.2.7. F. Hoffmann-La Roche Ltd

10.2.8. Sekisui Medical Co., Ltd 

10.2.9. Siemens Healthineers AG 

10.2.10.           Thermo Fisher Scientific

10.2.11.           ALPCO

10.2.12.           Beckman Coulter, Inc

10.2.13.           Theradiag

10.2.14.           Grifols S.A.

10.2.15.           Ark Diagnostics, Inc.

10.2.16.           Immundiagnostik Ag

10.2.17.           Biotez Berlin Buch Gmbh

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
5989
Security Code field cannot be blank!

Frequently Asked Questions

The Therapeutic Drug Monitoring Consumables Market Size is valued at USD 2.20 Bn in 2023 and is predicted to reach USD 4.42 Bn by the year 2031

The Therapeutic Drug Monitoring Consumables Market is expected to grow at an 9.5% CAGR during the forecast period for 2024-2031.

Abbott Laboratories, Alere, Inc., bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Exagen Inc, F. Hoffmann-La Roche Ltd, Sekisui Medical Co.,

Product, Technology, Class of drugs, and End user are the key segments of the Therapeutic Drug Monitoring Consumables Market.

North American region is leading the Therapeutic Drug Monitoring Consumables Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying